Cord blood mesenchymal stromal cell-conditioned medium protects endothelial cells via STAT3 signaling

Cellular Physiology and Biochemistry

Volumn 34, Issue 3, 2014, Pages 646-657

  Bader, Andreas Matthaeus ^a   Brodarac, Andreja ^a   Klose, Kristin ^a   Bieback, Karen ^b   Choi, Yeong Hoon ^c   Kang, Kyung Sun ^d   Kurtz, Andreas ^a,d   Stamm, Christof ^a,e  

^a Berlin Brandenburg Center of Regenerative Therapies (BCRT)   (Germany)

^b Institute of Transfusion Medicine and Immunology   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Seoul National University   (South Korea)

^e DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Cell therapy; Cord blood; Endothelial cell; Ischemia; Stem cell

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXYGEN; PROTEIN BCL 2; PROTEIN KINASE B; SCATTER FACTOR; STAT3 PROTEIN; VASCULOTROPIN; CULTURE MEDIUM; PRIMER DNA; STAT3 PROTEIN, HUMAN;

ADHERENT CELL; APOPTOSIS; ARTICLE; BRDU ASSAY; CELL COUNT; CELL MEMBRANE; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CORD BLOOD MESENCHYMAL STROMAL CELL; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; INTRACELLULAR SIGNALING; MESENCHYMAL STROMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAINING; UMBILICAL CORD BLOOD; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; WST-8 ASSAY; CULTURE MEDIUM; CYTOLOGY; FETUS BLOOD; METABOLISM; NUCLEOTIDE SEQUENCE; VALIDATION STUDY;

BASE SEQUENCE; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; FETAL BLOOD; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84906609891     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000363030     Document Type: Article

References (35)

1. Yang SS, Kim NR, Park KB, Do YS, Roh K, Kang KS, Kim DI: A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease. Int J Stem Cells 2013;6:37-44.
2. Gupta PK, Chullikana A, Parakh R, Desai S, Das A, Gottipamula S, Krishnamurthy S, Anthony N, Pherwani A, Majumdar AS: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med 2013;11:143.
3. Lee HC, An SG, Lee HW, Park JS, Cha KS, Hong TJ, Park JH, Lee SY, Kim SP, Kim YD, Chung SW, Bae YC, Shin YB, Kim JI, Jung JS: Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ J 2012;76:1750-1760.
4. Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ: Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 2011;50:280-289.
5. Liew A, O'Brien T. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther 2012;3:28.
6. Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S: Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004;287:H2670-2676.
7. Bhang SH, Lee S, Shin JY, Lee TJ, Kim BS: Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization. Tissue Eng Part A 2012;18:2138-2147.
8. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE: Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94:678-685.
9. Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, Goumans MJ, Strijder C, Sze SK, Choo A, Piek JJ, Doevendans PA, Pasterkamp G, de Kleijn DP: Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 2011;6:206-214.
10. Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH, Lee YS, Lee KS, Park HK, Kang KS: Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006;24:1620-1626.
11. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-1301.
12. Bader AM, Brodarac A, Klose K, Bieback K, Choi YH, Kurtz A, Stamm C: Mechanisms of paracrine cardioprotection by cord blood mesenchymal stromal cells. Eur J Cardiothorac Surg 2014;45:983-992.
13. Klose K, Roy R, Brodarac A, Kurtz A, Ode A, Kang KS, Bieback K, Choi YH, Stamm C: Impact of heart failure on the behavior of human neonatal stem cells in vitro. J Transl Med 2013;11:236.
14. Thery C, Amigorena S, Raposo G, Clayton A: Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;Chapter 3:Unit 3.22. Doi: 10.1002/0471143030.cb0322s30.
15. Anwar S, Speciale A, Fratantonio D, Cristani M, Saija A, Virgili F, Cimino F: Cyanidin-3-O-glucoside modulates intracellular redox status and prevents HIF-1 stabilization in endothelial cells in vitro exposed to chronic hypoxia. Toxicol Lett 2014;226:206-213.
16. Yang YY, Shang J, Liu HG: Role of endoplasmic reticular stress in aortic endothelial apoptosis induced by intermittent/persistent hypoxia. Chin Med J (Engl) 2013;126:4517-4523.
17. Lee C, Cheng W, Chang M, Su Y, Chen C, Hsieh F: Hypoxia-induced apoptosis in endothelial cells and embryonic stem cells. Apoptosis 2005;10:887-894.
18. Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, Wang YQ, Cao XF, Lv J, Xiao FJ, Yang Y, Guo ZK: Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev 2012;21:3289-3297.
19. Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H: Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 2014;92:387-397.
20. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007;292:F1626-1635.
21. Zhang B, Yang S, Zhang Y, Sun Z, Xu W, Ye S: Co-culture of mesenchymal stem cells with umbilical vein endothelial cells under hypoxic condition. J Huazhong Univ Sci Technolog Med Sci 2012;32:173-180.
22. Zachary I: VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem Soc Trans 2003;31:1171-1177.
23. Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC, Donia M, Fagone P, Malaponte G, Nicoletti F, Libra M, Milella M, Tafuri A, Bonati A, Basecke J, Cocco L, Evangelisti C, Martelli AM, Montalto G, Cervello M, McCubrey JA: Roles of the Raf/MEK/ ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY) 2011;3:192-222.
24. Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ: Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007;25:2363-2370.
25. Fujio Y, Maeda M, Mohri T, Obana M, Iwakura T, Hayama A, Yamashita T, Nakayama H, Azuma J: Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases. J Pharmacol Sci 2011;117:213-222.
26. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B: Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 2009;1171:59-76.
27. Przybyt E, Krenning G, Brinker MG, Harmsen MC: Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2. J Transl Med 2013;11:39.
28. Iso Y, Rao KS, Poole CN, Tarikuz Zaman AK, Curril I, Sobel BE, Kajstura J, Anversa P, Spees JL: Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction. Stem Cells 2014;32:674-683.
29. Shabbir A, Zisa D, Lin H, Mastri M, Roloff G, Suzuki G, Lee T: Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair. Am J Physiol Heart Circ Physiol 2010;299:H1428-1438.
30. Bhattacharya S, Ray RM, Johnson LR: STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem J 2005;392:335-344.
31. Choi HJ, Smithgall TE: HIV-1 Nef promotes survival of TF-1 macrophages by inducing Bcl-XL expression in an extracellular signal-regulated kinase-dependent manner. J Biol Chem 2004;279:51688-51696.
32. Kun D, Xiang-Lin C, Ming Z, Qi L: Chlamydia inhibit host cell apoptosis by inducing Bag-1 via the MAPK/ ERK survival pathway. Apoptosis 2013;18:1083-1092.
33. Zhao L, Eghbali-Webb M: Release of pro-and anti-angiogenic factors by human cardiac fibroblasts: effects on DNA synthesis and protection under hypoxia in human endothelial cells. Biochim Biophys Acta 2001;1538:273-282.
34. Tsai MJ, Tsai SK, Hu BR, Liou DY, Huang SL, Huang MC, Huang WC, Cheng H, Huang SS: Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. J Biomed Sci 2014;21:5.
35. Du Z, Wei C, Cheng K, Han B, Yan J, Zhang M, Peng C, Liu Y: Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation. J Surg Res 2013;183:907-915.